Literature DB >> 24699026

Cancer-initiating cells as target for prevention of recurring disease etiology: role of these malignant putative progenitor cells in relapse or metastasis of human cervical carcinoma.

Bharathi Ramdass, Abhay Chowdhari, Prasad Koka.   

Abstract

Evidence suggests that there is a link between high-risk human papillomaviruses (HPVs) and cervical cancer. Studies indicate that persistence of high risk HPVs may determine progression to more severe stages of cervical disease, while the majority of HPV infections are transient and do not seem to be important in cervical carcinogenesis. Earlier studies in different cancers have shown that tumor initiating cells TICs are responsible for tumor formation and progression and interestingly, they are endowed with stem/ progenitor cell properties. In particular, TICs share with stem cells the key feature of self-renewal. The most efficacious therapeutic intervention for cervical cancer is probably vaccination. This review gives an overview on cervical cancer and its potential therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24699026     DOI: jsc.2014.8.3/4.233

Source DB:  PubMed          Journal:  J Stem Cells        ISSN: 1556-8539


  3 in total

1.  Vaginal Stump Ligation for Cervical Cancer.

Authors:  Yanling Yang; Yang Liu; Guilin Li; Lei Li; Peng Geng; Hongjuan Song
Journal:  Iran J Public Health       Date:  2017-10       Impact factor: 1.429

Review 2.  Human papillomavirus induced transformation in cervical and head and neck cancers.

Authors:  Allie K Adams; Trisha M Wise-Draper; Susanne I Wells
Journal:  Cancers (Basel)       Date:  2014-09-15       Impact factor: 6.639

3.  Induction of artificial cancer stem cells from tongue cancer cells by defined reprogramming factors.

Authors:  Koji Harada; Tarannum Ferdous; Dan Cui; Yasuhiro Kuramitsu; Takuya Matsumoto; Eiji Ikeda; Hideyuki Okano; Yoshiya Ueyama
Journal:  BMC Cancer       Date:  2016-07-27       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.